echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > J Hepatol: How do I decide who will receive the next liver transplant?

    J Hepatol: How do I decide who will receive the next liver transplant?

    • Last Update: 2021-01-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In the United States and Europe, the priority of liver transplantation follows the principle of "the highest priority for the disease".
    , however, for patients with hepatocellular carcinoma (liver cancer, HCC), priority is based on binary tumor criteria (e.g., Milan) to speed up transplantation of "acceptable" patients with prognosis for transplantation.
    risk scores developed to overcome the limitations of these binary standards (e.g., Metroticket, HALT-HCC) are not sufficient for waiting for prioritization because they focus only on HCC-related pre-porting factors.
    , David and others tried to use HCC-related and non-HCC-related variables to develop risk scores to predict post-transplant survival in HCC patients.
    a retrospective queue study using national registration data from patients receiving liver transplants (DDLT) from deceased recipients between 27 February 2002 and 31 December 2018.
    Cox regression model analysis focused on 5- and 10-year survival rates, using manual variable selection to estimate the β coefficient of the risk score, calculating the absolute predicted survival time, and comparing it with the existing risk score.
    the probability of survival after transplantation in patients with different scores was 11 variables in 6,502 adult liver cancer patients who had liver transplants.
    0.62 (95% CI 0.57 to 0.67) and 0.65 (95% CI 0.58 to 0.72), respectively, with no statistical difference compared to Metroticket and HALT-HCC ratings.
    LITES-HCC scores were able to distinguish patients based on post-transplant survival rates in patients who met Milan and UCSF.
    , David and others have developed and validated a risk scoring method that predicts survival after transplantation in patients with liver cancer.
    By incorporating HCC-related and non-HCC-related variables (e.g., age, chronic kidney disease), this scoring method allows transplant professionals to prioritize liver cancer patients to be transplanted based on the predicted post-transplant survival rate, which can be used to determine who can receive transplants first.
    : In the case of a shortage of transplanted organs, this method can indeed bring some benefits.
    But according to who is the most likely to survive the transplant to decide who receives liver transplant, this practice is very European and American, as in the new crown outbreak, Europe and the United States do not give patients over 60 years of age to use a ventilator ...
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.